NCT06181513View on ClinicalTrials.gov

Probiotics in Mild Alzheimer's Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

July 1, 2025

Study Completion Date

December 1, 2025

Conditions
Neurodegenerative DiseasesCognition Disorders in Old Age
Interventions
DRUG

Probiotic Blend Capsule

20 million CFU (Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus helveticus, Bifidobacterium breve)

Trial Locations (1)

Unknown

RECRUITING

The Cyprus Institute of Neurology and Genetics, Nicosia

All Listed Sponsors
collaborator

Cyprus Institute of Neurology and Genetics

OTHER

lead

University of Nicosia

OTHER